NBY News and Press, NovaBay Pharmaceuticals Inc. From 05/07/24

MONTREAL, May 07, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce that, following re-sampling of historic Vior drill holes from the Foothills Project, assay results confirm the presence of phospha...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three months ended March 31, 2024 after market close on Thursday, May 9, 2024 and will hold an investment community conference call that day beginning at 4:30 p.m. Eastern time....

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, April 30, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“ NioBay ” or the “ Company ”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce...

NovaBay ® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wound care products, announces a new and enhanced marketing program that includes text message communications (SMS) and targeted email programs aimed at enhancing the...

2024-04-22 01:43:28 ET More on NovaBay NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report Seeking Alpha’s Quant Rating on NovaBay Historical earnings data for NovaBay Read the full article on Seeking Alpha F...

NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) announces that on April 18, 2024 it received a notice from the NYSE American LLC stating that the Company is below compliance with the NYSE American continued listing standards set forth in Sections 1003(a)(ii) and (iii) of the NYSE...

2024-04-17 07:23:47 ET More on NovaBay Seeking Alpha’s Quant Rating on NovaBay Historical earnings data for NovaBay Financial information for NovaBay Read the full article on Seeking Alpha For further details see: NovaBay Pharmaceuticals sh...

Growth driven by efficient Avenova ® direct-to-consumer e-marketing programs NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY) reports preliminary net revenue for its eyecare and wound care business for the first quarter of 2024 of $2.6 million, a 13% increase ...

2024-03-26 17:03:28 ET More on NovaBay Seeking Alpha’s Quant Rating on NovaBay Historical earnings data for NovaBay Financial information for NovaBay Read the full article on Seeking Alpha For further details see: NovaBay GAAP EPS of -$1.33...

Q4 net sales from the eyecare and wound care segment grew 10% over the prior year with higher sales from the Avenova ® physician dispensed and OTC channels, and from branded wound care products Sales and marketing expenses for the quarter declined 27% reflecting digital marketing...